Sign up FAST! Login

Study finds a marijuana derivative might reduce seizure frequency and may be safe for use in treatment-resistant epilepsy.

Stashed in: Marijuana

To save this post, select a stash from drop-down menu or type in a new one:


Our findings suggest that cannabidiol might reduce seizure frequency and might have an adequate safety profile in children and young adults with highly treatment-resistant epilepsy. Randomised controlled trials are warranted to characterise the safety profile and true efficacy of this compound.


Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

You May Also Like: